Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CLOV
stocks logo

CLOV

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
468.30M
+31.45%
--
--
466.94M
+41.08%
--
--
464.99M
+38%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Clover Health Investments, Corp. (CLOV) for FY2025, with the revenue forecasts being adjusted by -0.02% over the past three months. During the same period, the stock price has changed by -16.11%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.02%
In Past 3 Month
Stock Price
Go Down
down Image
-16.11%
In Past 3 Month
3 Analyst Rating
up Image0
Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is 4.75 USD with a low forecast of 3.75 USD and a high forecast of 6.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
up Image0
Current: 3.020
sliders
Low
3.75
Averages
4.75
High
6.00
up Image0
Current: 3.020
sliders
Low
3.75
Averages
4.75
High
6.00
Canaccord Genuity
Richard Close
Strong Buy
Maintains
$4.2 → $4.5
2025-03-03
Reason
Canaccord Genuity
Richard Close
Price Target
$4.2 → $4.5
2025-03-03
Maintains
Strong Buy
Reason
Craig-Hallum
Matt Hewitt
Strong Buy
Initiates
$6
2024-12-17
Reason
Craig-Hallum
Matt Hewitt
Price Target
$6
2024-12-17
Initiates
Strong Buy
Reason
Craig-Hallum analyst Matt Hewitt initiated coverage of Clover Health with a Buy rating and $6 price target.
UBS
Jonathan Yong
Hold
Initiates
$4
2024-10-07
Reason
UBS
Jonathan Yong
Price Target
$4
2024-10-07
Initiates
Hold
Reason
UBS initiated coverage of Clover Health with a Neutral rating and $4 price target. Clover Health has done a good job improving its core operations and medical costs, and the improved Star rating of 3.5, based on preliminary Planfinder data, also gives increasing confidence on improving Medicare Advantage enrollment growth and overall top-line growth, which will allow Clover to accelerate growth while maintaining reasonable economics, the analyst tells investors in a research note. However, the firm sees all this as appropriately captured in the stock price.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Clover Health Investments Corp (CLOV.O) is -22.19, compared to its 5-year average forward P/E of -9.41. For a more detailed relative valuation and DCF analysis to assess Clover Health Investments Corp 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.41
Current PE
-22.19
Overvalued PE
-1.26
Undervalued PE
-17.57

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
4.58
Current EV/EBITDA
22.07
Overvalued EV/EBITDA
23.69
Undervalued EV/EBITDA
-14.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.94
Current PS
0.77
Overvalued PS
2.05
Undervalued PS
-0.18

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

CLOV News & Events

Events Timeline

(ET)
2025-07-09
08:40:28
Clover Health launches New Jersey community pharmacy program with IPC
select
2025-06-30 (ET)
2025-06-30
08:40:10
Clover Health set to join Russell 3000 Index
select
2025-05-06 (ET)
2025-05-06
17:11:20
Clover Health narrows FY25 adjusted EBITDA view to $50M-$70M from $45M-$70M
select
Sign Up For More Events
Sign Up For More Events

News

Preview
2.0
07-08Benzinga
What's Going On With Clover Health Stock?

  • Clover Health Stock Performance: Clover Health Investments Corp. (CLOV) shares rose 5% on Tuesday, contributing to a total increase of over 12% in the past week, following its inclusion in the Russell 3000 Index, which enhances visibility and investment interest.

  • Upcoming Earnings Report: The company is set to report its second-quarter earnings on August 5, with analysts expecting a loss of 3 cents per share and revenue of approximately $468.3 million, while also projecting full-year insurance revenue between $1.8 billion and $1.875 billion.

Preview
7.0
07-02NASDAQ.COM
Centene Pulls 2025 Guidance as Marketplace Growth Falters

  • Centene Corporation Earnings Guidance: Centene Corporation has withdrawn its earnings guidance for 2025 due to unexpected shifts in the health insurance marketplace, anticipating a $1.8 billion shortfall in net risk adjustment revenues, which significantly impacts its profit margins.

  • Market Performance and Future Adjustments: Despite challenges in Medicaid and rising costs, Centene plans to adjust its rates for 2026 to account for higher morbidity, while its Medicare segments are performing better than expected; shares have dropped 43.3% year-to-date compared to a 24.4% decline in the industry.

Preview
5.0
07-01NASDAQ.COM
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment

  • Cigna Group Coverage Announcement: Cigna Group will begin covering RhinAer, a minimally invasive treatment for chronic rhinitis, starting September 15, 2025, providing access to over 15 million members and marking a significant shift in patient care options.

  • Clinical Effectiveness and Market Position: The decision reflects confidence in RhinAer’s clinical efficacy, supported by extensive research, positioning Cigna as a leader in evidence-based, patient-focused healthcare solutions while also enhancing its market value.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Clover Health Investments Corp (CLOV) stock price today?

The current price of CLOV is 3.02 USD — it has increased 1.34 % in the last trading day.

arrow icon

What is Clover Health Investments Corp (CLOV)'s business?

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

arrow icon

What is the price predicton of CLOV Stock?

Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is 4.75 USD with a low forecast of 3.75 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Clover Health Investments Corp (CLOV)'s revenue for the last quarter?

Clover Health Investments Corp revenue for the last quarter amounts to 462.33M USD, increased 33.27 % YoY.

arrow icon

What is Clover Health Investments Corp (CLOV)'s earnings per share (EPS) for the last quarter?

Clover Health Investments Corp. EPS for the last quarter amounts to -0.00 USD, decreased -100.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Clover Health Investments Corp (CLOV)'s fundamentals?

The market is revising Downward the revenue expectations for Clover Health Investments, Corp. (CLOV) for FY2025, with the revenue forecasts being adjusted by -0.02% over the past three months. During the same period, the stock price has changed by -16.11%.
arrow icon

How many employees does Clover Health Investments Corp (CLOV). have?

Clover Health Investments Corp (CLOV) has 570 emplpoyees as of July 17 2025.

arrow icon

What is Clover Health Investments Corp (CLOV) market cap?

Today CLOV has the market capitalization of 1.54B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free